ArticleTherapeutic advances in neurological disorders2019

Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis.

Kyomin Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.